HR Execs on the Move


 
Today`s Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside of the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships.
  • Number of Employees: 10K-50K
  • Annual Revenue: > $1 Billion
  • www.merck.com
  • 2000 Galloping Hill Road
    Kenilworth, NJ USA 07033
  • Phone: 908.740.4000

Executives

Name Title Contact Details
Frederic-Andre Vennat
Executive Director, Program Management Office Lead, Human Health Profile
Jacob Langbein
Director, Global Marketing Profile
Greg Elwood
Associate Director, US Payer Marketing Profile
Ali Guerrieri
Associate Director Consumer Marketing Profile
Anoop Kumar
Director Financial Systems, Life Science Profile

Similar Companies

Emcure Pharmaceuticals Limited

Emcure Pharmaceuticals, headquartered at Pune in West India, is an Indian pharmaceutical company.

Hospice Provider Group Inc

Hospice Provider Group Inc is a Sarasota, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Theseus Pharmaceuticals

Theseus is a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies. Theseus is developing next-generation tyrosine kinase inhibitors (TKIs): "pan-variant" targeted therapies that address all major drug resistance mutations. Theseus` lead product candidate, THE-630, is a pan-variant KIT inhibitor for the treatment of patients with advanced gastrointestinal stromal tumors (GIST), whose cancer has developed resistance to earlier lines of kinase inhibitor therapy. Theseus is also developing a fourth-generation, selective epidermal growth factor receptor (EGFR) inhibitor for C797S-mediated resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer (NSCLC).

Champions Oncology

Champions Oncology is a company that develops technology solutions and services for personalizing the development and use of oncology drugs. Their technology-enabled research platforms empower biopharma to create a comprehensive understanding of tumor ...

ZYUS

ZYUS is a Canadian-based life sciences company focused on the global development and commercialization of phyto-therapeutics, commonly known as plant-made solutions. We are committed to delivering high-quality standardized therapeutic formulations that comply with Good Manufacturing Practices (GMP) to provide targeted relief for our patients.